FDA seizes discontinued unapproved cosmetic eyelash enhancement
WASHINGTON The Food and Drug Administration has announced that nearly 13,000 tubes of Age Intervention Eyelash have been seized because the product may, in some users, lead to decreased vision.
According to the FDA, Age Intervention Eyelash, sold and distributed by San Jose, Calif.-based Jan Marini Skin Research, is considered an unapproved and misbranded drug because it is promoted to increase eyelash growth. Before a new drug product may be legally marketed, it must be shown to be safe and effective, and approved by the FDA.
Authorities also consider the seized product, valued at about $2 million, to be an adulterated cosmetic. The product contains bimatoprost, an active ingredient in an FDA-approved drug to treat elevated pressure inside the eye.
For patients already using the prescription medication, the cosmetic product may increase the risk of optic nerve damage because the extra dose of bimatoprost may decrease the prescription drug’s effectiveness, the FDA stated. Damage to the optic nerve may lead to decreased vision and possibly blindness.
In addition, using the product may cause other adverse effects in certain people due to the bimatoprost, including macular edema, or swelling of the retina, and uveitis, or inflammation of the eye, which may lead to decreased vision.
Jan Marini Skin Research notified the FDA that it ceased manufacturing and shipping any Age Intervention Eyelash product containing bimatoprost last year.
The FDA is urging consumers, dermatologists and estheticians who may still have Age Intervention Eyelash to stop using it and discard any remaining product. The FDA also recommends that consumers consult their health care provider if they have experienced any adverse events that they suspect are related to the product’s use.
Lornamead’s Finesse gets a new look
STAMFORD, Conn. Personal care company Lornamead is celebrating Finesse’s 25th anniversary with new packaging throughout the entire range of shampoos, conditioners and styling products.
The new packaging features a three-dimensional burst, designed to reflect the nature of all three formulations using primary colors. For example, Enhancing Shampoo is blue, Moisturizing Shampoo is pink and Volumizing is green.
“On the occasion of the brand’s 25th birthday, it was fitting that this popular hair care line from the ‘80s got an update,” stated George Russell, chief executive officer of Lornamead.
New York-based firm Muts & Joy designed the new packaging.
L’Oreal to acquire Turkish hair care company
PARIS L’Oreal group has announced an agreement to acquire Turkish hair care products company Canan.
The deal is subject to closing conditions and customary governmental review, including antitrust clearance. L’Oreal expects that the acquisition of Canan will be accretive from 2009.
Founded in 1981, Canan achieved sales of €26 million in 2006, mainly through its brand Ipek, which is in fourth position in the mass-market hair care segment.
Ipek is widely distributed throughout Turkey, both in mass market and traditional retail outlets. Canan has a factory near Istanbul.
According to Patrick Rabain, president of consumer products, “The Turkish cosmetics market is expanding strongly and has a very large growth potential. The acquisition of Canan will bolster our positions in hair care products, the largest segment in the market. With its commercial dynamism and its extensive presence in retailing channels, Canan will also accelerate the development of the division’s other brands.”